The Denial of Adverse Event Risk Following Immunization and the Loss of Informed Consent - A Perspective
Scathing 2018 Review of Human Vaccine Development, Safety, Efficacy, and Regulatory Management
By Peter A. McCullough, MD, MPH
Like many of you, I have invested thousands of hours reading, writing, watching videos, being interviewed—all in honing myself into a vaccine expert. A recent paper caught my attention as an all-out venting of frustration on how the vaccine industry has gone wrong after nearly 200 years of vaccine ideology from the very first attempts at inoculating children with cowpox.
In a paper from K. Paul Stoller in Acta Scientific Pediatrics one year before the COVID-19 pandemic, many concerning issues with vaccine research, human trials, reporting of safety, efficacy, and the regulatory machine are fully ventilated. I was amazed at how many issues Stoller hit: Institute of Medicine, FDA, CDC, WHO, sudden infant death syndrome, autism, epidemic peanut and other new allergies, Type 1 diabetes mellitus, thimerosal, aluminum, SV40, vaccine failures, and fraud everywhere in the Bio-Pharmaceutical Complex.
Please take the time to read this paper and understand the frustrations with the Bio-Pharmaceutical Complex were building before the SARS-CoV-2 outbreak arrived at our shores. The COVID-19 vaccine debacle has brought many of the issues Stoller outlined in 2018 into contemporary view. The public is steaming.
Please subscribe to Courageous Discourse as a paying or founder member so we can continue to bring you the truth.
Courageous Discourse™ with Dr. Peter McCullough & John Leake is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Peter A. McCullough, MD, MPH
President, McCullough Foundation